ATRX/DAXX loss/mutations and ALT positivity are associated with a more aggressive tumour phenotype (larger tumours, grade stage), chromosomal instability, metastatic disease and survival, with the absence of ATRX/DAXX being an independent predictor of survival on multivariable analysis [60]. The gene discussed is ATRX; the disease is metastatic neoplasm.